Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
The CD18 hypomorphic (CD18hypo) PL/J mouse model clinically resembling human psoriasis is characterized by reduced expression of the common chain of beta2 integrins (CD11/CD18) to only 2-16% of WT levels. Previously we found that this chronic psoriasiform skin inflammation also depends on the presence of CD4+ T cells. Herein we investigated the role of macrophages in this CD18hypo mouse model. Activated macrophages were significantly increased in lesional skin as well as in inflamed skin draining lymph nodes (DLNs) of affected CD18hypo mice and were identified as being an important source of TNF-alpha in vivo. Both depletion of macrophages and neutralization of TNF-alpha resulted in a significant alleviation of psoriasiform skin inflammation. As monocyte chemotactic protein 1 was enhanced in lesional skin of affected CD18hypo mice, we intradermally injected recombinant murine monocyte chemotactic protein-1 (rJE/MCP-1) alone or in combination with rTNF-alpha into the skin of healthy CD18hypo mice. Only simultaneous injection of rJE/MCP-1 and rTNF-alpha, but neither substance alone, resulted in the induction of psoriasiform skin inflammation around the injection sites with recruitment and activation of macrophages. Collectively, our data suggest that maintenance of psoriasiform skin inflammation critically depends on efficient recruitment and activation of macrophages with sufficient release of TNF-alpha.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrins: A family of cell surface receptors
HYNES, R. (1987) · Cell · doi:10.1016/0092-8674(87)90233-9 · Cited by 4,249 · cited 1×
“These integrins (CD11/CD18) are leukocyte adhesion molecules exclusively expressed on hemopoietic cells and are responsible for cell-cell contacts in a variety of inflammatory interactions (23).”
Leukocyte-endothelial adhesion molecules
Carlos, T., & Harlan, J. (1994) · Blood · doi:10.1182/blood.v84.7.2068.2068 · Cited by 2,701 · cited 1×
“These heterodimeric molecules interact with more than 20 known ligands, the most prominent of which belong to the ICAM family (24).”
Rooijen, N. V., & Sanders, A. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90012-4 · Cited by 1,779
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Etanercept as Monotherapy in Patients with Psoriasis
Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., & Gottlieb, A. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030409 · Cited by 1,175
Subpopulations of Mouse Blood Monocytes Differ in Maturation Stage and Inflammatory Response
Sunderkötter, C., Nikolic, T., Dillon, M. J., van Rooijen, N., Stehling, M., Drevets, D. A., & Leenen, P. J. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4410 · Cited by 1,124 · cited 1×
“A recent report further indicated that MCP-1 binds to the chemokine receptor CCR2, which was demonstrated to be expressed on peripheral blood monocytes from patients with psoriasis (42) and also on a subtype of murine monocytes principally involved in inflammation (38).”
Lu, B., Rutledge, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R., Gerard, C., & Rollins, B. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.601 · Cited by 1,017 · cited 2×
“Since MCP-1 expression is high at the epidermal/dermal junction in human plaque psoriasis and MCP-1 has strong macrophage-recruiting properties (3, 40), we next investigated MCP-1 expression and its function in our mouse model in more detail.”
Schön, M. P., & Boehncke, W.-H. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041320 · Cited by 955
Sano, S., Chan, K. S., Carbajal, S., Clifford, J., Peavey, M., Kiguchi, K., Itami, S., Nickoloff, B. J., & DiGiovanni, J. (2005) · Nature Medicine · doi:10.1038/nm1162 · Cited by 752 · cited 2×
“Most of these, however, reveal only a single or a few aspects resembling human psoriasis (11–14).”
Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins
Zenz, R., Eferl, R., Kenner, L., Florin, L., Hummerich, L., Mehic, D., Scheuch, H., Angel, P., Tschachler, E., & Wagner, E. F. (2005) · Nature · doi:10.1038/nature03963 · Cited by 599 · cited 2×
“Most of these, however, reveal only a single or a few aspects resembling human psoriasis (11–14).”
Cited by
Items 101–200 of 275
Uttarkar, S., Brembilla, N. C., & Boehncke, W. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.12.1011 · Cited by 48
Kodji, X., Arkless, K. L., Kee, Z., Cleary, S. J., Aubdool, A. A., Evans, E., Caton, P., Pitchford, S. C., & Brain, S. D. (2018) · The FASEB Journal · doi:10.1096/fj.201800395rr · Cited by 47
Liu, Y., Yang, G., Zhang, J., Xing, K., Dai, L., Cheng, L., Liu, J., Deng, J. V., Shi, G., Li, C., et al. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.07.036 · Cited by 45
Lorthois, I., Asselineau, D., Seyler, N., & Pouliot, R. (2017) · Mediators of Inflammation · doi:10.1155/2017/7215072 · Cited by 44
“[44] Hypomorphic PL/J CD18 Psoriasis-like skin inflammation Abnormal keratinocyte proliferation/ differentiation, subcorneal”
BackgroundMononuclear phagocyte system in kidney disease and repair
Alikhan, M. A., & Ricardo, S. D. (2013) · Nephrology · doi:10.1111/nep.12014 · Cited by 47
Anti-inflammatory role of 15-lipoxygenase contributes to the maintenance of skin integrity in mice
Kim, S.-N., Akindehin, S., Kwon, H.-J., Son, Y.-H., Saha, A., Jung, Y.-S., Seong, J. K., Lim, K., Sung, J.-H., Maddipati, K. R., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-27221-7 · Cited by 44
Pal, H. C., Chamcheu, J. C., Adhami, V. M., Wood, G. S., Elmets, C. A., Mukhtar, H., & Afaq, F. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13513 · Cited by 42
Advances in the modulation of ROS and transdermal administration for anti-psoriatic nanotherapies
Xu, J., Chen, H., Qian, H., Wang, F., & Xu, Y. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01651-y · Cited by 43
Shu, Y., Xue, R., Gao, Y., Zhang, W., & Wang, J. (2023) · Journal of Materials Chemistry B · doi:10.1039/d2tb02189g · Cited by 41
Nie, Z., Scott, G. D., Weis, P., Itakura, A., Fryer, A. D., & Jacoby, D. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01393.x · Cited by 44
“Etanercept is a human dimeric fusion protein consisting of p75 TNF-a receptor linked to the Fc of IgG1 (Lesslauer et al., 1991; Peppel et al., 1991; Suffredini et al., 1995; Ritchlin et al., 2003; Wang et al., 2006; Baumann et al., 2007).”
BackgroundThree decades of psoriasis research: where has it led us?
Sabat, R., Sterry, W., Philipp, S., & Wolk, K. (2007) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2007.08.002 · Cited by 49
Gaire, B. P., Lee, C., Kim, W., Sapkota, A., Lee, D. Y., & Choi, J. W. (2020) · Cells · doi:10.3390/cells9081753 · Cited by 41
“Among these, infiltration and activation of macrophages have been proven to be critical pathogenic events in psoriasis [5,6].”
BackgroundThe RNase MCPIP3 promotes skin inflammation by orchestrating myeloid cytokine response
Liu, B., Huang, J., Ashraf, A., Rahaman, O., Lou, J., Wang, L., Cai, P., Wen, J., Anwaar, S., Liu, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24352-w · Cited by 43
“R el at iv e ex pr es si on Nfkbiz 3' UTR (1-1294) MΦ”
BackgroundGuo, H., Li, M., & Liu, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042112 · Cited by 41
“IL-17, alone or synergistically with TNF-α acting on keratinocytes, results in the transcription of many psoriasis-related genes, including CCL20, CXCL1, -2, -3, and -8 chemokines [29].”
BackgroundInfluentialWatanabe, S., Iwata, Y., Fukushima, H., Saito, K., Tanaka, Y., Hasegawa, Y., Akiyama, M., & Sugiura, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-76864-y · Cited by 39
α1β1 Integrin-Mediated Adhesion Inhibits Macrophage Exit from a Peripheral Inflammatory Lesion
Becker, H., Rullo, J., Chen, M., Ghazarian, M., Bak, S., Xiao, H., Hay, J. B., & Cybulsky, M. I. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202097 · Cited by 47
Basu, A., Munir, S., Mulaw, M. A., Singh, K., Crișan, D., Sindrilaru, A., Treiber, N., Wlaschek, M., Huber-Lang, M. S., Gebhard, F., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24425-9 · Cited by 41
Wang, Y., Qi, C., Feng, F., Hu, X., Zhao, N., Zhao, J., Di, T., Meng, Y., Yang, D., Zhu, H., et al. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s416417 · Cited by 38
“recent evidence has highlighted the role of macrophages in psoriasis pathogenesis.(5,6) Macrophages are a significant source of TNF-a and IL-23.”
BackgroundKönig, S., Nitzki, F., Uhmann, A., Dittmann, K., Theiss-Suennemann, J., Herrmann, M. K. A., Reichardt, H. M., Schwendener, R. A., Pukrop, T., Schulz‐Schaeffer, W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093555 · Cited by 36
“This is in contrast to other reports showing that LC are resistant to clodronate [28].”
ResultPlasmin Plays an Essential Role in Amplification of Psoriasiform Skin Inflammation in Mice
Li, Q., Fang, K., Zhang, W., Shen, X., Xu, Q., Wang, H., Yu, X., Leng, Q., & Wang, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016483 · Cited by 35
“to sustain a cycle of inflammation leading to the psoriatic phenotype [9,10,11,12].”
BackgroundSelf-citationMacrophages in dermatology: pathogenic roles and targeted therapeutics
Kuraitis, D., Rosenthal, N. A., Boh, E., & McBurney, E. I. (2021) · Archives of Dermatological Research · doi:10.1007/s00403-021-02207-0 · Cited by 36
Macrophages Mediate Psoriasis via Mincle-Dependent Mechanism in Mice
Tan, R., Zhong, X., Han, R.-Y., Xie, K.-H., Jia, J., Yang, Y., Cheng, M., Chun-yan, Y., Lan, H. Y., & Wang, L. (2022) · Cell Death Discovery · doi:10.1038/s41420-023-01444-8 · Cited by 35
Bone marrow stromal cells as immunomodulators. A primer for dermatologists
Németh, K., & Mezey, É. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.10.004 · Cited by 48
“The role of T lymphocytes in psoriasis has been known for a long time [70,71] while the importance of macrophages is a recent addition to our understanding of how psoriasis develops [72,73].”
BackgroundPsoriasiform Inflammation Is Associated with Mitochondrial Fission/GDAP1L1 Signaling in Macrophages
Alalaiwe, A. S., Chen, C., Chang, Z., Sung, J.-T., Chuang, S.-Y., & Fang, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910410 · Cited by 32
Wang, L., Yang, L., Gao, L., Gao, T., Li, W., & Liu, Y. (2007) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2007.00734.x · Cited by 38
“There were evidences showing that macrophages are the main source of TNF-α, and that macrophages are important to maintain the psoriasis phenotype in experimental models (Clark & Kupper, 2006; Stratis et al., 2006; Wang et al., 2006).”
BackgroundCosta, S. E., Marini, O., Bevilacqua, D., DeFranco, A. L., Hou, B., Lonardi, S., Vermi, W., Rodegher, P., Panato, A., Tagliaro, F., et al. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ma0217-054rr · Cited by 32
Feng, L., Song, P., Xu, F., Xu, L., Shao, F., Guo, M., Huang, W., Kong, L., Wu, X., & Xu, Q. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.02.021 · Cited by 34
Kragstrup, T. W., Jalilian, B., Hvid, M., Kjærgaard, A. G., Østgård, R., Schiøttz‐Christensen, B., Jurik, A. G., Robinson, W. H., Vorup‐Jensen, T., & Deleuran, B. W. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4471 · Cited by 31
NETosis of psoriasis: a critical step in amplifying the inflammatory response
Zhang, J., Feng, Y., & Shi, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1374934 · Cited by 33
“Studies on mouse models of psoriasis have demonstrated a strong correlation between macrophages and the severity of psoriasis (76, 77).”
BackgroundReview: A Contemporary, Multifaced Insight into Psoriasis Pathogenesis
Dascălu, R. C., Bărbulescu, A. L., Stoica, L. E., Dinescu, Ș. C., Biță, C. E., Popoviciu, H. V., Ionescu, R. A., & Vreju, F. A. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14050535 · Cited by 34
“Antigen-presenting cells derived from monocytes are shown to be present in psoriatic lesions, with TNF secretion upon activation and regulation of angiogenesis by releasing VEGF [121,122].”
BackgroundKeeren, K., Friedrich, M., Gebuhr, I., Philipp, S., Sabat, R., Sterry, W., Brandt, C., Meisel, C., Grütz, G., Volk, H., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804351 · Cited by 29
Odegaard, J. I., Vats, D., Zhang, L., Ricardo-González, R. R., Smith, K. L., Sykes, D. B., Kamps, M. P., & Chawla, A. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0906590 · Cited by 32
Chong, S. Z., Tan, K. W., Wong, F. H. S., Chua, Y. L., Tang, Y., Ng, L. G., Angeli, V., & Kemeny, D. M. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.403 · Cited by 29
“The primary expression of TNF-a and iNOS have also been commonly attributed to activated macrophages in the skin (Wang et al., 2006; Tuckermann et al., 2007).”
BackgroundSphingosine Kinases are Involved in Macrophage NLRP3 Inflammasome Transcriptional Induction
Syed, S. N., Weigert, A., & Brüne, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134733 · Cited by 29
“Monocytes and macrophages are critical players psoriasiform skin inflammation [43,85] and in the tumor microenvironment [44], and they are being implicated to play tumor-promoting roles in human renal cell carcinoma (RCC) patients.”
BackgroundPhilipp, S., Wolk, K., Kreutzer, S., Wallace, E., Ludwig, N., Roewert, J. C., Höflich, C., Volk, H., Sterry, W., & Sabat, R. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.6.817 · Cited by 33
“Very recently, two independent studies demonstrated that activated macrophages are essential in two different murine models for chronic psoriasis-like skin inflammation [59,60].”
BackgroundMacrophage Functions in Psoriasis: Lessons from Mouse Models
Nazimek, K., & Bryniarski, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105306 · Cited by 28
“Furthermore, activated skin macrophages were identified as an important source of TNF α for psoriatic inflammation in the CD18 hypomorphic (CD18hypo) PL/J mouse model [42].”
BackgroundFan, J., Zhu, T., Tian, X., Liu, S., & Zhang, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1372303 · Cited by 27
Wang, P., Lin, T.-Y., Yang, P., Fang, J., Li, W., & Pan, T. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113798 · Cited by 31
Lee, W., & Kim, W. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.12.026 · Cited by 31
Rowley, S. M., Kuriakose, T., Dockery, L. M., Tran-Ngyuen, T., Gingerich, A. D., Wei, L., & Watford, W. T. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.559344 · Cited by 28
Periyathambi, P., Sastry, T. P., Anandasadagopan, S. K., & Manickavasagam, K. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.09.018 · Cited by 27
Heier, I., Søyland, E., Krogstad, A., Rodríguez‐Gallego, C., Nenseter, M. S., & Jahnsen, F. L. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10430.x · Cited by 31
Ribbert, T., Thepen, T., Tur, M. K., Fischer, R., Hühn, M., & Barth, S. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09824.x · Cited by 26
Yehuda, H., Khatib, S., Sussan, I., Musa, R., Vaya, J., & Tamir, S. (2009) · BioFactors · doi:10.1002/biof.32 · Cited by 33
“[40] has identified the macrophage as an important source of TNF-a, which is a significant cytokine in psoriasis, as shown by the fact that etanercept, a TNF-a neutralizing agent, is effective in the treatment of human psoriasis [38] and in the alleviation of psoriasiform skin inflammation in mice [40].”
BackgroundResultKularatne, S. A., Bélanger, M.-J., Meng, X., Connolly, B., Vanko, A., Suresch, D. L., Guenther, I., Wang, S., Low, P. S., Mcquade, P. S., et al. (2013) · Molecular Pharmaceutics · doi:10.1021/mp4001684 · Cited by 26
Advances in Psoriasis Research: Decoding Immune Circuits and Developing Novel Therapies
Wang, L., Liu, R., Tang, Y.-L., Ma, Y.-F., Wang, G., Ruan, Q., & Zheng, S. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189233 · Cited by 34
“It was found that in the CD18 hypomorphic psoriasiform mouse model, activated macrophages played a pivotal role in chronic inflammation through TNF-α release, with either macrophage depletion or TNF-α neutralization significantly ameliorated skin pathology [118].”
TNF-alpha modulates adipose macrophage polarization to M1 phenotype in response to scorpion venom
Ait‐Lounis, A., & Laraba‐Djebari, F. (2015) · Inflammation Research · doi:10.1007/s00011-015-0876-z · Cited by 25
“TNF-a has previously been shown to maintain the activation state of macrophages in an autocrine manner [31].”
BackgroundMacrophage S1PR1 Signaling Alters Angiogenesis and Lymphangiogenesis During Skin Inflammation
Syed, S. N., Raue, R., Weigert, A., von Knethen, A., & Brüne, B. (2019) · Cells · doi:10.3390/cells8080785 · Cited by 26
Arakura, F., Hida, S., Ichikawa, E., Yajima, C., Nakajima, S., Saida, T., & Taki, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3249 · Cited by 24
“Regardless of the stages at which these genetic manipulations initiated the pathogenic process, one of the endpoints seemed to be prominent macrophage infiltration in the skin in not only IKK2-deficient and CD18 hypomorphic models (48, 49), but also in IRF-2 / BN mice (Fig.”
BackgroundNeutrophil extracellular traps promote macrophage inflammation in psoriasis
Li, R., Xiong, Y., Ma, L., Peng, C. X., Qi, S., Gao, R., Wang, P., Li, F., Li, J., Li, Q., et al. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.110308 · Cited by 23
Reactive Oxygen Species in Psoriasis and Psoriasis Arthritis: Relevance to Human Disease
Khmaladze, I., Nandakumar, K. S., & Holmdahl, R. (2015) · International Archives of Allergy and Immunology · doi:10.1159/000375401 · Cited by 27
Chemokine receptors in psoriasis
Singh, T. P., Lee, C. H., & Farber, J. M. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.838220 · Cited by 25
“In mouse models of psoriasis, using principally the F4/80 antigen to identify macrophages, macrophages were shown to express TNF-a, and their depletion using liposomes eliminated pathology [175-177].”
BackgroundMethodThe Experimental Animal Models in Psoriasis Research: A Comprehensive Review
Parab, S. B., & Doshi, G. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109897 · Cited by 23
Role of wound macrophages in skin flap loss or survival in an experimental diabetes model
Schürmann, C., Seitz, O., Sader, R., Pfeilschifter, J. M., Goren, I., & Frank, S. (2010) · British journal of surgery · doi:10.1002/bjs.7123 · Cited by 23
Serum peptides as putative modulators of inflammation in psoriasis
Matsuura, T., Sato, M., Nagai, K., Sato, T., Arito, M., Omoteyama, K., Suematsu, N., Okamoto, K., Kato, T., Soma, Y., et al. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2017.03.014 · Cited by 24
Treatments for psoriasis: A journey from classical to advanced therapies. How far have we reached?
Hari, G., Kishore, A., & Pai, K. S. R. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175147 · Cited by 21
Cardiometabolic risk in psoriasis: differential effects of biologic agents
Kaplan, M. J. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3461 · Cited by 22
Lerner, I., Zcharia, E., Neuman, T., Hermano, E., Rubinstein, A. M., Vlodavsky, I., & Elkin, M. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1496-9 · Cited by 21
Liu, L., Yin, P., Yang, R., Zhang, G., Wu, C., Zheng, Y., Wu, S., & Liu, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1351908 · Cited by 20
Unveiling multifaceted roles of myeloid innate immune cells in the pathogenesis of psoriasis
Park, S.-H., Jang, J., Kim, H. J., & Jung, Y. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101306 · Cited by 25
Gatzka, M., Hainzl, A., Peters, T., Singh, K., Tasdogan, A., Wlaschek, M., & Scharffetter‐Kochanek, K. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300976 · Cited by 22
“Important elements in chronification of psoriasiform dermatitis in the CD18 PL/J mouse model are additional defects in other immune cells, in particular, defects in CD4CD25 Tregs, that possess an increased tendency to convert into Th17 cells (31, 32, 40) and alterations in macrophages (30).”
BackgroundMethodWang, H., von Rohrscheidt, J., Röhrbein, J. H., Peters, T., Sindrilaru, A., Keß, D., Preissner, K. T., & Scharffetter‐Kochanek, K. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.310 · Cited by 19
“…we reported a polygenic mouse model that develops a T-cell-mediated psoriasiform skin disease in homozygous CD18 hypomorphic (CD18hypo) PL/J mice with a severe reduction of CD18 expression to only 2–16% of wild-type (wt) levels (Wilson et al., 1993; Bullard et al., 1996; Wang et al., 2006, 2008).”
BackgroundMethodSelf-citationTanita, K., Fujimura, T., Sato, Y., Lyu, C., & Aiba, S. (2018) · Experimental Dermatology · doi:10.1111/exd.13779 · Cited by 20
Song, L., Chang, R., Sun, X., Lu, L., Gao, H., Lu, H., Lin, R., Xu, X., Liu, Z., & Zhan, L. (2021) · Communications Biology · doi:10.1038/s42003-021-01730-0 · Cited by 19
Targeting leukocyte recruitment in the treatment of psoriasis
Li, Y. Y., Zollner, T. M., & Schön, M. P. (2008) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2007.11.002 · Cited by 23
Li, Q., Syrovets, T., Simmet, T., Ding, J., Xu, J., Chen, W.-D., Zhu, D.-L., & Gao, P.-J. (2013) · Experimental biology and medicine · doi:10.1177/1535370212473700 · Cited by 20
Diversity and function of regulatory T cells in health and autoimmune diseases
Lu, Y., & Man, X. (2025) · Journal of Autoimmunity · doi:10.1016/j.jaut.2025.103357 · Cited by 21
Immunoregulatory effects of traditional Chinese medicine and its ingredients on psoriasis
Feng, W., Liu, H., Liang, C.-L., Huang, H., Chen, Y., & Dai, Z. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114896 · Cited by 18
Hayashi, D., SUGAYA, H., OHKOSHI, T., SEKIZAWA, K., Takatsu, H., Shinkai, T., & Urano, S. (2012) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.58.161 · Cited by 18
Screening Anti-Inflammatory Effects of Flavanones Solutions
Bustos-Salgado, P., Andrade-Carrera, B., Domínguez-Villegas, V., Díaz‐Garrido, N., Rodríguez-Lagunas, M. J., Badı́a, J., Baldomà, L., Mallandrich, M., Calpena, A. C., & Garduño-Ramı́rez, M. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168878 · Cited by 17
M2 ‐like macrophages polarized by Foxp3− Treg‐of‐B cells ameliorate imiquimod‐induced psoriasis
Huang, J., Lin, Y., Wang, L., & Chiang, B. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17748 · Cited by 18
Wang, H., Keß, D., Lindqvist, A.-K., Peters, T., Sindrilaru, A., Wlaschek, M., Blakytny, R., Holmdahl, R., & Scharffetter‐Kochanek, K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5520 · Cited by 17
“As the psoriasiform skin disease critically depends on the presence of CD4 T cells and activated TNF- releasing macrophages (8, 37), cryosections derived from skin of affected PSD1 congenic and control mice were stained with antimouse CD4, anti-mouse F4/80, and anti-TNF- mAb.”
BackgroundMethodResultSelf-citationLeys, L. J., Wang, Y., Paulsboe, S. E., Edelmayer, R. M., Salte, K., Wetter, J. B., Namovic, M. T., Phillips, L. A., Dunstan, R. W., Gauvin, D. M., et al. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.14899 · Cited by 18
Association of the Psoriatic Microenvironment With Treatment Response
Wang, G., Miao, Y., Kim, N., Sweren, E., Kang, S., Hu, Z., & Garza, L. A. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.2118 · Cited by 18
Role of free reactive iron in psoriasis
Kar, M., Ghosh, A., & Mukhopadhyay, S. (2008) · Indian Journal of Dermatology Venereology and Leprology · doi:10.4103/0378-6323.41390 · Cited by 16
“Reduced level of serum super oxide dismutase (SOD), glutathione peroxidase (GPX), and elevated level of nitric oxide (NO) has been reported.[2-4] The causative factor of such oxidative stress is not yet clearly known.”
BackgroundSoluble Tumor Necrosis Factor Receptors Shed by Breast Tumor Cells Inhibit Macrophage Chemotaxis
Rego, S. L., Swamydas, M., Kidiyoor, A., Helms, R., Piante, A. D., Lance, A. L., Mukherjee, P., & Dréau, D. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0009 · Cited by 15
Pan, Y., Zou, J., Hu, T., Zhu, Z., Zhang, Z., Chen, W., & Lu, Y. (2025) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-025-00776-8 · Cited by 20
“Removing macrophages or SHP2 in murine models reduces psoriasis inflammation [60, 61].”
Singh, K., Koroma, A. K., Pandey, R., Wang, Y., Cheng, J., Haas, P., Aghapour, M., Krug, L., Hainzl, A., Wlaschek, M., et al. (2025) · Advanced Science · doi:10.1002/advs.202504920 · Cited by 21
Zhao, Z. Q., Chen, B. Z., Gan, J. L., Feng, Y. H., Liang, L., Yu, L., Wang, Z. Y., Abbaszadeh, S., Shahbazi, M., Yu, R., et al. (2024) · Nano Research · doi:10.1007/s12274-024-6711-5 · Cited by 14
Skin under Tnf influence: how regulatory T cells work against macrophages in psoriasis
Gatzka, M. (2016) · The Journal of Pathology · doi:10.1002/path.4820 · Cited by 14
“For instance, the phenotype of CD18hypo PL/J mice, which spontaneously develop T cell-mediated and macrophage-mediated psoriasiform dermatitis at approximately 12–14 weeks of age as a consequence of reduced CD18/β2-integrin expression levels, could be ameliorated either by depletion of macrophages with clodronate [7]…”
ResultOtobe, S., Hisamoto, T., Miyagaki, T., Morimura, S., Suga, H., Sugaya, M., & Sato, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197401 · Cited by 15
“In some experiments, mice were subcutaneously injected into their right ear with 20 μL of chlodronate liposomes or control liposomes (Formu Max, Sunnyvale, CA, USA) to deplete cutaneous macrophages 24 h before the elicitation as previously described [35].”
MethodUnique Cell Subpopulations and Disease Progression Markers in Canines with Atopic Dermatitis
Sparling, B. A. T. E., Moss, N., Kaur, G., Clark, D. L., Hawkins, R. D., & Drechsler, Y. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200304 · Cited by 13
Architecture of skin inflammation in psoriasis revealed by spatial transcriptomics
Gniadecki, R., Osman, M. S., Hennessey, D., O’Keefe, S. L., Thomsen, S. F., & Iyer, A. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109771 · Cited by 17
Michaelis, K., Wallbrecht, K., Kerstan, A., Beyersdorf, N., Williams, C. A., Kerkau, T., Wang, X., Hünig, T., & Schön, M. P. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.01031.x · Cited by 14
The immunological and genetic aspects in psoriasis
Sun, L., & Zhang, X. (2014) · Applied Informatics · doi:10.1186/s40535-014-0003-1 · Cited by 14
“Previous researches have suggested that the maintenance of psoriasiform skin inflammation critically depends on efficient recruitment and activation of macrophages with a sufficient release of TNF-α (Wang et al. 2006).”
BackgroundWalvekar, K. P., Tirunavalli, S. K., Eedara, A., Chandra, Y., Kuncha, M., Kumar, A. B. R., Sistla, R., Andugulapati, S. B., & Chilaka, S. (2024) · Inflammation · doi:10.1007/s10753-024-02103-5 · Cited by 16
“Macrophages are known to accumulate in higher numbers in the early stages of inflammation and were shown to play a major role in psoriasis development [10–12].”
Primary sensory neuron-derived miR-let-7b underlies stress-elicited psoriasis
Yang, H., Wang, Y., Chang, W., Zhai, M., Du, W., Jiang, W., Xiang, Y., Qin, G., Yu, J. M., Gong, Y., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.11.005 · Cited by 13
Kelly‐Sell, M. J., & Gudjonsson, J. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-44797-3.00001-3 · Cited by 12
Impaired Treg-DC interactions contribute to autoimmunity in leukocyte adhesion deficiency type 1
Klaus, T., Wilson, A. S., Vicari, E., Hadaschik, E. N., Klein, M., Helbich, S. S., Kamenjarin, N., Hodapp, K., Schunke, J., Haist, M., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.162580 · Cited by 13
“In contrast to CD11a-/- mice with no significant phenotype (17), CD18 hypomorphic (CD18hypo)PL/J mice with up to 16% residual expression of CD18 are characterized by a skin disease that closely resembles human psoriasis (18, 19).”
Upregulation of ANGPTL6 in mouse keratinocytes enhances susceptibility to psoriasis
Tanigawa, H., Miyata, K., Tian, Z., Aoi, J., Kadomatsu, T., Fukushima, S., Ogata, A., Takeda, N., Zhao, J., Zhu, S., et al. (2016) · Scientific Reports · doi:10.1038/srep34690 · Cited by 12
O'Daly, J. A., Lezama, R. A., & Gleason, J. (2009) · Archives of Dermatological Research · doi:10.1007/s00403-009-0940-z · Cited by 13
“the recruitment of macrophages and subsequent release of TNF- [ 30 ].”
BackgroundFederico, A., Pavel, A., Möbus, L., McKean, D. M., del Giudice, G., Fortino, V., Niehues, H., Rastrick, J., Eyerich, K., Eyerich, S., et al. (2022) · Human Genomics · doi:10.1186/s40246-022-00431-x · Cited by 16
Li, M., Yu, W., Liu, Z., & Liu, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115705 · Cited by 10
“Furthermore, murine studies have demonstrated that clodronate liposome-mediated depletion of macrophages alleviates the severity of psoriasiform skin inflammation [19,20].”
BackgroundSkin immunity and inflammation: cellular interactions and communication
Narayanan, D., Sim, S.-L., & Kumari, S. (2025) · Clinical & Translational Immunology · doi:10.1002/cti2.70053 · Cited by 10
“41,162,165 Of note, pro-inflammatory cytokines, TNF, IL-17A and IL-1 b were significantly reduced after macrophage depletion.”
Infliximab in the treatment of plaque psoriasis
Saraceno, R., & Gottlieb, A. B. (2007) · Therapy · doi:10.2217/14750708.4.4.399 · Cited by 10
“T lymphocytes and dendritic antigen-presenting cells (APCs) have been considered to be of major importance in the immunopathogenesis of psoriasis, and current evidence suggests that epidermal changes are caused by the actions of these cells in skin lesions [5,6].”
BackgroundEffect of Efalizumab on Neutrophil and Monocyte Functions in Patients with Psoriasis
CAPSONI, F., Ongari, A. M., Frigerio, E., Taglioni, M., & Altomare, G. F. (2008) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200802100224 · Cited by 10
Huang, T., Chen, S., Ding, K., Yuan, L., Lv, W., Chen, K., Liu, Y., Ma, D.-Z., Zhang, X., Wang, X., et al. (2025) · Advanced Science · doi:10.1002/advs.202501408 · Cited by 17
Wang, B., Li, D., Pan, C., Wang, Y., Tan, Y., Yang, Y., Liu, H., Yao, Z., Zhang, H., & Wang, Z. (2025) · Experimental Dermatology · doi:10.1111/exd.70152 · Cited by 9
Yin, Y., Yan, C., Pei, X., Rao, J., Wu, L., Xue, Y., Sun, H., & Sheng, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1736082 · Cited by 11
Histone Modifications and DNA Methylation in Psoriasis: A Cellular Perspective
Pan, J., Chen, S., Chen, X., Song, Y., & Cheng, H. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-024-09014-1 · Cited by 11
“Existing studies have reported that the depletion of skin macrophages can significantly improve psoriasiform skin inflammation by reducing the release of inflammatory cytokines [91].”
Metadata
- Authors
- Wang, H.
- Affiliations
- Universität Ulm (DE)
- Corresponding author
- Wang, H.
- ORCID
- Wang, H.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-08-01
- Volume
- 116
- Issue
- 8
- Pages
- 2105-2114
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1523400
- OpenAlex
- W2136157736
- Cited by
- 276
- References
- 66
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 20 · 2023: 6 · 2022: 15 · 2021: 9 · 2020: 11 · 2019: 12 · 2018: 11 · 2017: 11 · 2016: 9 · 2015: 13 · 2014: 13 · 2013: 16 · 2012: 9
- FWCI
- 8.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (SU 195/3-1, SFB 497)
- Universität Ulm
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Rheumatology › Spondyloarthritis Studies and Treatments
- Keywords
- psoriasis, macrophages, beta2 integrins, CD4+ T cells, TNF-α, MCP-1, macrophage recruitment, skin inflammation, macrophage depletion, draining lymph nodes
- MeSH terms
- Animals, Disease Models, Animal, Inflammation, Macrophage Activation, Mice, Inbred Strains, Mutation, Phenotype, Psoriasis, Recombinant Proteins, RNA, Messenger, T-Lymphocytes, CD18 Antigens, CD11 Antigens, Chemokine CCL2, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.